Healthcare Sector Stocks
The Healthcare sector has a total of 1056 stocks, with a combined market cap of $9.41 trillion, total revenue of $4.67 trillion and a weighted average PE ratio of 50.27.
Market Cap
9.41T
Revenue
4.67T
Profits
187.1B
PE Ratio
50.27
Profit Margin
4.01%
Dividend Yield
0.38%
1055 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.03T | 0.11% | 1,544,678 | 79.67B |
| 2 | JNJ | Johnson & Johnson | 653.78B | 2.05% | 3,454,598 | 97.93B |
| 3 | ABBV | AbbVie Inc. | 458.04B | 1.08% | 2,158,480 | 64.39B |
| 4 | MRK | Merck & Co., Inc. | 370.05B | 1.51% | 5,611,319 | 66.57B |
| 5 | UNH | UnitedHealth Group Incorporated | 355.61B | 1.74% | 2,270,511 | 450.53B |
| 6 | NVS | Novartis AG | 289.79B | 6.19% | 3,598,330 | 56.69B |
| 7 | AZN | AstraZeneca PLC | 250.99B | 0.02% | 2,050,065 | 61.37B |
| 8 | AMGN | Amgen Inc. | 236.16B | 1.61% | 1,184,643 | 38.10B |
| 9 | TMO | Thermo Fisher Scientific Inc. | 222.14B | -2.64% | 921,558 | 46.34B |
| 10 | NVO | Novo Nordisk A/S | 201.62B | -0.46% | 5,783,140 | 50.34B |
| 11 | ABT | Abbott Laboratories | 188.87B | -1.10% | 4,507,456 | 46.59B |
| 12 | GILD | Gilead Sciences, Inc. | 185.27B | 2.10% | 2,612,049 | 30.46B |
| 13 | PFE | Pfizer Inc. | 162.61B | 0.25% | 29,599,062 | 63.70B |
| 14 | DHR | Danaher Corporation | 145.38B | -3.17% | 2,222,956 | 25.11B |
| 15 | VRTX | Vertex Pharmaceuticals Incorporated | 138.97B | 0.69% | 396,735 | 12.59B |
| 16 | BMY | Bristol-Myers Squibb Company | 136.58B | 0.07% | 3,905,224 | 49.19B |
| 17 | ISRG | Intuitive Surgical, Inc. | 130.21B | -2.19% | 1,166,477 | 11.03B |
| 18 | CVS | CVS Health Corporation | 124.06B | 3.29% | 5,182,312 | 412.65B |
| 19 | SYK | Stryker Corporation | 122.13B | -1.67% | 1,407,744 | 25.84B |
| 20 | MDT | Medtronic plc | 117.95B | 1.65% | 14,735,427 | 37.54B |
| 21 | SNY | Sanofi | 106.75B | 0.21% | 1,569,110 | 55.89B |
| 22 | MCK | McKesson Corporation | 105.76B | 2.46% | 453,895 | 410.98B |
| 23 | GSK | GSK plc | 100.70B | 0.74% | 2,064,410 | 44.05B |
| 24 | HCA | HCA Healthcare, Inc. | 89.75B | 0.02% | 849,327 | 78.01B |
| 25 | ELV | Elevance Health, Inc. | 87.43B | 2.71% | 510,196 | 201.11B |
| 26 | REGN | Regeneron Pharmaceuticals, Inc. | 82.24B | 3.06% | 411,472 | 15.53B |
| 27 | CI | The Cigna Group | 74.46B | 2.07% | 735,448 | 282.38B |
| 28 | BSX | Boston Scientific Corporation | 69.63B | -0.53% | 7,340,982 | 21.00B |
| 29 | ARGX | argenx SE | 64.25B | -0.52% | 125,350 | 5.32B |
| 30 | COR | Cencora, Inc. | 63.01B | 2.04% | 810,147 | 332.77B |
| 31 | MRNA | Moderna, Inc. | 61.39B | 9.57% | 21,962,996 | 2.23B |
| 32 | TAK | Takeda Pharmaceutical Company Limited | 58.30B | 1.42% | 1,500,174 | 28.42B |
| 33 | CAH | Cardinal Health, Inc. | 55.53B | 1.76% | 612,808 | 254.25B |
| 34 | EW | Edwards Lifesciences Corporation | 52.12B | -0.35% | 1,478,485 | 6.51B |
| 35 | BDX | Becton, Dickinson and Company | 50.89B | -0.68% | 744,737 | 22.48B |
| 36 | HUM | Humana Inc. | 47.19B | 2.55% | 737,374 | 145.68B |
| 37 | NTRA | Natera, Inc. | 46.81B | 0.85% | 660,240 | 2.71B |
| 38 | MDLN | Medline Inc. | 45.71B | -0.74% | 6,045,930 | 29.94B |
| 39 | VEEV | Veeva Systems Inc. | 45.26B | -2.16% | 816,473 | 3.46B |
| 40 | RVMD | Revolution Medicines, Inc. | 44.64B | 1.30% | 1,134,892 | - |
| 41 | HLN | Haleon plc | 44.08B | 0.50% | 8,996,502 | 14.80B |
| 42 | IDXX | IDEXX Laboratories, Inc. | 42.85B | -2.30% | 237,271 | 4.55B |
| 43 | IQV | IQVIA Holdings Inc. | 42.44B | -1.28% | 860,429 | 16.98B |
| 44 | A | Agilent Technologies, Inc. | 42.27B | -2.38% | 1,369,736 | 7.37B |
| 45 | TEVA | Teva Pharmaceutical Industries Limited | 42.13B | 0.28% | 2,337,048 | 17.32B |
| 46 | ONC | BeOne Medicines AG | 40.69B | -0.48% | 217,825 | 6.13B |
| 47 | WAT | Waters Corporation | 39.82B | -2.24% | 346,172 | 4.64B |
| 48 | RPRX | Royalty Pharma plc | 35.66B | 0.99% | 1,478,529 | 2.54B |
| 49 | ALC | Alcon Inc. | 35.02B | -0.50% | 1,083,697 | 10.86B |
| 50 | DXCM | DexCom, Inc. | 34.02B | -0.99% | 1,233,856 | 4.97B |
| 51 | RMD | ResMed Inc. | 33.40B | -3.55% | 564,497 | 5.65B |
| 52 | ALNY | Alnylam Pharmaceuticals, Inc. | 32.90B | 2.14% | 1,211,818 | 4.80B |
| 53 | CNC | Centene Corporation | 32.12B | 1.05% | 2,833,705 | 180.30B |
| 54 | ZTS | Zoetis Inc. | 31.93B | 0.22% | 2,515,638 | 9.53B |
| 55 | BIIB | Biogen Inc. | 31.86B | -0.47% | 477,180 | 10.03B |
| 56 | GEHC | GE HealthCare Technologies Inc. | 31.78B | -1.24% | 1,469,678 | 21.27B |
| 57 | ILMN | Illumina, Inc. | 31.34B | -2.84% | 945,589 | 4.49B |
| 58 | MTD | Mettler-Toledo International Inc. | 27.57B | -2.08% | 112,178 | 4.13B |
| 59 | LH | Labcorp Holdings Inc. | 26.61B | -1.36% | 330,286 | 14.35B |
| 60 | INSM | Insmed Incorporated | 26.50B | -0.38% | 902,112 | 1.14B |
| 61 | DGX | Quest Diagnostics Incorporated | 26.11B | -1.55% | 477,821 | 11.56B |
| 62 | PHG | Koninklijke Philips N.V. | 26.01B | - | 573,702 | 20.18B |
| 63 | BNTX | BioNTech SE | 25.35B | -0.68% | 585,407 | 3.03B |
| 64 | INCY | Incyte Corporation | 25.23B | 1.01% | 702,194 | 5.82B |
| 65 | ROIV | Roivant Sciences Ltd. | 25.01B | -0.06% | 2,900,277 | 7.53M |
| 66 | WST | West Pharmaceutical Services, Inc. | 23.88B | -0.54% | 261,448 | 3.33B |
| 67 | STE | STERIS plc | 22.36B | -1.42% | 247,382 | 6.04B |
| 68 | GH | Guardant Health, Inc. | 22.12B | 3.65% | 1,689,119 | 1.18B |
| 69 | UTHR | United Therapeutics Corporation | 22.07B | 0.82% | 187,561 | 3.15B |
| 70 | THC | Tenet Healthcare Corporation | 21.40B | -0.06% | 595,278 | 21.81B |
| 71 | GMAB | Genmab A/S | 19.88B | 0.27% | 1,281,529 | 4.13B |
| 72 | VTRS | Viatris Inc. | 19.07B | 0.55% | 3,895,990 | 14.74B |
| 73 | ZBH | Zimmer Biomet Holdings, Inc. | 18.94B | -0.76% | 822,570 | 8.51B |
| 74 | ASND | Ascendis Pharma A/S | 17.13B | -0.84% | 436,485 | 1.20B |
| 75 | MEDP | Medpace Holdings, Inc. | 16.31B | -1.65% | 62,589 | 2.78B |
| 76 | JAZZ | Jazz Pharmaceuticals plc | 15.94B | -2.06% | 728,333 | 4.60B |
| 77 | NBIX | Neurocrine Biosciences, Inc. | 15.89B | 1.48% | 539,397 | 3.37B |
| 78 | SOLV | Solventum Corporation | 15.54B | 0.24% | 590,085 | 8.31B |
| 79 | BBIO | BridgeBio Pharma, Inc. | 14.99B | 0.09% | 620,822 | 713.07M |
| 80 | RVTY | Revvity, Inc. | 14.13B | -1.57% | 2,127,897 | 2.91B |
| 81 | EXEL | Exelixis, Inc. | 14.05B | 3.81% | 1,386,690 | 2.44B |
| 82 | COO | The Cooper Companies, Inc. | 13.50B | -1.27% | 720,947 | 4.23B |
| 83 | CRL | Charles River Laboratories International, Inc. | 13.43B | -2.37% | 413,448 | 4.00B |
| 84 | BAX | Baxter International Inc. | 13.07B | -2.77% | 3,485,234 | 11.47B |
| 85 | PEN | Penumbra, Inc. | 12.72B | -0.09% | 91,842 | 1.50B |
| 86 | BMRN | BioMarin Pharmaceutical Inc. | 12.49B | -1.07% | 1,036,333 | 3.41B |
| 87 | ICLR | ICON Public Limited Company | 12.45B | -2.22% | 402,748 | 8.29B |
| 88 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.40B | -0.64% | 88,842 | 1.28B |
| 89 | BTSG | BrightSpring Health Services, Inc. | 12.32B | 1.25% | 767,366 | 14.37B |
| 90 | HALO | Halozyme Therapeutics, Inc. | 12.23B | 1.18% | 702,540 | 1.66B |
| 91 | CORT | Corcept Therapeutics Incorporated | 12.22B | -0.29% | 544,641 | 830.81M |
| 92 | SNN | Smith & Nephew plc | 12.18B | 0.66% | 2,450,852 | 6.30B |
| 93 | FMS | Fresenius Medical Care AG | 12.15B | -0.11% | 633,790 | 22.19B |
| 94 | ELAN | Elanco Animal Health Incorporated | 12.05B | 0.84% | 2,117,284 | 5.02B |
| 95 | EHC | Encompass Health Corporation | 12.05B | 1.61% | 601,397 | 6.21B |
| 96 | ARWR | Arrowhead Pharmaceuticals, Inc. | 11.67B | 0.30% | 710,286 | 669.50M |
| 97 | SMMT | Summit Therapeutics Inc. | 11.43B | 5.21% | 3,131,795 | - |
| 98 | TECH | Bio-Techne Corporation | 11.32B | -0.14% | 2,183,678 | 1.22B |
| 99 | TEM | Tempus AI, Inc. | 11.27B | -0.94% | 5,339,966 | 1.43B |
| 100 | DVA | DaVita Inc. | 11.21B | -0.11% | 385,439 | 14.01B |
| 101 | ALGN | Align Technology, Inc. | 10.98B | -3.25% | 312,394 | 4.14B |
| 102 | GMED | Globus Medical, Inc. | 10.76B | -1.52% | 590,787 | 3.14B |
| 103 | AXSM | Axsome Therapeutics, Inc. | 10.74B | 3.30% | 349,725 | 776.57M |
| 104 | KRYS | Krystal Biotech, Inc. | 10.68B | 0.43% | 121,489 | 440.48M |
| 105 | ABVX | ABIVAX Société Anonyme | 10.60B | 1.70% | 834,448 | 5.67M |
| 106 | MOH | Molina Healthcare, Inc. | 10.60B | 2.34% | 427,965 | 42.47B |
| 107 | GKOS | Glaukos Corporation | 10.44B | -1.42% | 286,944 | 612.84M |
| 108 | PODD | Insulet Corporation | 10.26B | -0.46% | 716,987 | 3.05B |
| 109 | RDY | Dr. Reddy's Laboratories Limited | 10.25B | 0.33% | 1,268,168 | 3.50B |
| 110 | BIO | Bio-Rad Laboratories, Inc. | 10.21B | -1.13% | 192,613 | 2.59B |
| 111 | APGE | Apogee Therapeutics, Inc. | 10.19B | -0.01% | 773,590 | - |
| 112 | UHS | Universal Health Services, Inc. | 10.04B | 0.03% | 280,803 | 18.11B |
| 113 | ENSG | The Ensign Group, Inc. | 10.01B | 0.58% | 106,707 | 5.49B |
| 114 | IONS | Ionis Pharmaceuticals, Inc. | 10.01B | -0.22% | 912,080 | 874.09M |
| 115 | CYTK | Cytokinetics, Incorporated | 10.00B | 1.48% | 1,105,460 | 67.67M |
| 116 | KYMR | Kymera Therapeutics, Inc. | 9.85B | -0.26% | 342,954 | 105.00M |
| 117 | HSIC | Henry Schein, Inc. | 9.84B | -1.70% | 368,371 | 13.60B |
| 118 | PRAX | Praxis Precision Medicines, Inc. | 9.80B | 0.19% | 203,692 | 7.46M |
| 119 | AVTR | Avantor, Inc. | 9.64B | -1.96% | 3,611,000 | 6.56B |
| 120 | RGEN | Repligen Corporation | 9.48B | -7.23% | 895,251 | 785.10M |
| 121 | PTGX | Protagonist Therapeutics, Inc. | 9.46B | -1.03% | 197,090 | 281.99M |
| 122 | OSCR | Oscar Health, Inc. | 9.19B | -0.57% | 4,023,181 | 15.32B |
| 123 | PCVX | Vaxcyte, Inc. | 9.02B | -0.18% | 947,483 | - |
| 124 | CRNX | Crinetics Pharmaceuticals, Inc. | 9.01B | - | - | 42.16M |
| 125 | QGEN | Qiagen N.V. | 8.95B | 0.02% | 1,890,903 | 2.10B |
| 126 | BRKR | Bruker Corporation | 8.53B | -3.46% | 1,262,235 | 3.50B |
| 127 | ATR | AptarGroup, Inc. | 8.37B | 0.07% | 240,220 | 3.93B |
| 128 | IBRX | ImmunityBio, Inc. | 8.37B | -0.63% | 4,471,104 | 165.79M |
| 129 | TWST | Twist Bioscience Corporation | 8.31B | -4.69% | 925,549 | 431.80M |
| 130 | IMVT | Immunovant, Inc. | 8.12B | -3.67% | 1,003,116 | - |
| 131 | HQY | HealthEquity, Inc. | 8.05B | 0.80% | 600,714 | 1.36B |
| 132 | ALKS | Alkermes plc | 7.92B | 0.49% | 658,405 | 1.67B |
| 133 | TXG | 10x Genomics, Inc. | 7.92B | -2.66% | 1,291,445 | 616.91M |
| 134 | TGTX | TG Therapeutics, Inc. | 7.92B | 2.82% | 2,296,019 | 799.54M |
| 135 | SYRE | Spyre Therapeutics, Inc. | 7.71B | -2.07% | 932,558 | - |
| 136 | HNGE | Hinge Health, Inc. | 7.29B | -2.41% | 895,066 | 720.06M |
| 137 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.19B | -1.57% | 198,063 | 239.92M |
| 138 | CAI | Caris Life Sciences, Inc. | 7.00B | -2.79% | 2,843,938 | 989.61M |
| 139 | GRFS | Grifols, S.A. | 6.82B | -0.13% | 137,727 | 8.48B |
| 140 | SRRK | Scholar Rock Holding Corporation | 6.81B | -1.53% | 516,169 | - |
| 141 | CGON | CG Oncology, Inc. | 6.73B | 1.01% | 288,942 | 6.23M |
| 142 | PACS | PACS Group, Inc. | 6.72B | 0.33% | 389,952 | 5.55B |
| 143 | CHE | Chemed Corporation | 6.72B | -0.45% | 86,146 | 2.60B |
| 144 | HIMS | Hims & Hers Health, Inc. | 6.65B | -3.65% | 5,498,575 | 2.58B |
| 145 | LNTH | Lantheus Holdings, Inc. | 6.58B | -0.08% | 1,091,054 | 1.56B |
| 146 | MIRM | Mirum Pharmaceuticals, Inc. | 6.40B | 0.55% | 253,679 | 618.07M |
| 147 | BLCO | Bausch + Lomb Corporation | 6.38B | 2.12% | 460,678 | 5.32B |
| 148 | BLTE | Belite Bio, Inc | 6.30B | 0.47% | 75,783 | - |
| 149 | MMED | MiniMed Group, Inc. | 6.28B | 10.39% | 4,891,570 | 3.10B |
| 150 | TVTX | Travere Therapeutics, Inc. | 6.21B | -0.66% | 698,201 | 591.33M |
| 151 | KNSA | Kiniksa Pharmaceuticals International, plc | 6.20B | 0.98% | 169,053 | 840.85M |
| 152 | AMRX | Amneal Pharmaceuticals, Inc. | 6.15B | 1.00% | 698,379 | 3.12B |
| 153 | ORKA | Oruka Therapeutics, Inc. | 6.07B | -0.98% | 399,614 | - |
| 154 | COGT | Cogent Biosciences, Inc. | 6.01B | -1.03% | 832,310 | - |
| 155 | LQDA | Liquidia Corporation | 6.00B | -1.70% | 896,226 | 450.91M |
| 156 | DNTH | Dianthus Therapeutics, Inc. | 5.96B | 0.93% | 316,459 | 1.90M |
| 157 | TFX | Teleflex Incorporated | 5.93B | -1.44% | 323,488 | 2.25B |
| 158 | RDNT | RadNet, Inc. | 5.91B | -0.87% | 472,363 | 2.27B |
| 159 | ERAS | Erasca, Inc. | 5.91B | -5.48% | 4,843,971 | - |
| 160 | PTCT | PTC Therapeutics, Inc. | 5.89B | 1.57% | 326,325 | 1.01B |
| 161 | XENE | Xenon Pharmaceuticals Inc. | 5.79B | -0.63% | 169,398 | 7.50M |
| 162 | STVN | Stevanato Group S.p.A. | 5.67B | -3.17% | 99,186 | 1.40B |
| 163 | LGND | Ligand Pharmaceuticals Incorporated | 5.65B | -0.17% | 128,050 | 290.54M |
| 164 | CRSP | CRISPR Therapeutics AG | 5.49B | -0.42% | 653,839 | 13.39M |
| 165 | MMSI | Merit Medical Systems, Inc. | 5.40B | -0.32% | 239,483 | 1.58B |
| 166 | SHC | Sotera Health Company | 5.31B | -1.48% | 880,317 | 1.22B |
| 167 | DFTX | Definium Therapeutics, Inc. | 5.18B | -2.87% | 1,143,076 | - |
| 168 | ACAD | ACADIA Pharmaceuticals Inc. | 4.98B | -0.10% | 424,095 | 1.14B |
| 169 | WAY | Waystar Holding Corp. | 4.95B | -1.41% | 1,332,527 | 1.21B |
| 170 | PBLS | Parabilis Medicines, Inc. | 4.81B | -0.15% | 415,644 | 148.00K |
| 171 | LFST | LifeStance Health Group, Inc. | 4.79B | 1.54% | 1,935,583 | 1.58B |
| 172 | DYN | Dyne Therapeutics, Inc. | 4.72B | -0.71% | 1,171,811 | - |
| 173 | DOCS | Doximity, Inc. | 4.70B | -1.24% | 1,126,849 | 655.57M |
| 174 | HAE | Haemonetics Corporation | 4.65B | -0.79% | 237,033 | 1.35B |
| 175 | EWTX | Edgewise Therapeutics, Inc. | 4.59B | 1.22% | 632,362 | - |
| 176 | CELC | Celcuity Inc. | 4.50B | 3.35% | 450,971 | - |
| 177 | BLLN | BillionToOne, Inc. | 4.43B | 3.60% | 340,418 | 397.41M |
| 178 | LIVN | LivaNova PLC | 4.42B | 0.53% | 344,436 | 1.47B |
| 179 | HTFL | HeartFlow, Inc. | 4.39B | 0.18% | 971,960 | 212.07M |
| 180 | CON | Concentra Group Holdings Parent, Inc. | 4.33B | 0.61% | 373,488 | 2.29B |
| 181 | NVST | Envista Holdings Corporation | 4.29B | -1.62% | 1,320,424 | 2.86B |
| 182 | ICUI | ICU Medical, Inc. | 4.27B | -1.19% | 199,796 | 2.16B |
| 183 | ITGR | Integer Holdings Corporation | 4.26B | 0.14% | 951,404 | 1.84B |
| 184 | ELVN | Enliven Therapeutics, Inc. | 4.25B | 0.24% | 868,002 | - |
| 185 | AMLX | Amylyx Pharmaceuticals, Inc. | 4.22B | -0.30% | 1,265,273 | -665.00K |
| 186 | MANE | Veradermics, Incorporated | 4.16B | 1.06% | 383,303 | - |
| 187 | LEGN | Legend Biotech Corporation | 4.12B | 2.36% | 871,398 | 1.27B |
| 188 | INDV | Indivior Pharmaceuticals, Inc. | 4.10B | -0.49% | 1,265,594 | 1.33B |
| 189 | RLAY | Relay Therapeutics, Inc. | 4.06B | 0.71% | 941,980 | 10.35M |
| 190 | IRTC | iRhythm Holdings, Inc. | 4.03B | 2.75% | 432,803 | 825.34M |
| 191 | ADPT | Adaptive Biotechnologies Corporation | 3.91B | -1.79% | 1,168,871 | 308.08M |
| 192 | VKTX | Viking Therapeutics, Inc. | 3.90B | 2.01% | 870,294 | - |
| 193 | IDYA | IDEAYA Biosciences, Inc. | 3.85B | -0.40% | 407,700 | 234.13M |
| 194 | TNGX | Tango Therapeutics, Inc. | 3.78B | -1.75% | 923,992 | 53.81M |
| 195 | RCUS | Arcus Biosciences, Inc. | 3.75B | 0.48% | 1,177,459 | 117.00M |
| 196 | PLSE | Pulse Biosciences, Inc. | 3.73B | 3.85% | 879,480 | 1.19M |
| 197 | DNLI | Denali Therapeutics Inc. | 3.72B | -1.94% | 949,167 | 3.60M |
| 198 | TLX | Telix Pharmaceuticals Limited | 3.71B | -2.16% | 164,735 | 890.79M |
| 199 | IOVA | Iovance Biotherapeutics, Inc. | 3.68B | -0.49% | 5,035,770 | 324.97M |
| 200 | ABCL | AbCellera Biologics Inc. | 3.65B | -1.92% | 3,360,757 | 66.17M |
| 201 | OGN | Organon & Co. | 3.61B | 0.04% | 2,730,888 | 6.13B |
| 202 | GRAL | GRAIL, Inc. | 3.58B | 1.05% | 267,871 | 165.26M |
| 203 | OPCH | Option Care Health, Inc. | 3.53B | 0.60% | 728,566 | 5.69B |
| 204 | VCYT | Veracyte, Inc. | 3.47B | -0.14% | 520,453 | 561.90M |
| 205 | NHC | National HealthCare Corporation | 3.45B | 1.88% | 103,734 | 1.56B |
| 206 | GPCR | Structure Therapeutics Inc. | 3.36B | 2.70% | 346,391 | - |
| 207 | QURE | uniQure N.V. | 3.32B | -1.60% | 415,584 | 18.67M |
| 208 | TARS | Tarsus Pharmaceuticals, Inc. | 3.25B | -0.31% | 347,496 | 606.33M |
| 209 | CLDX | Celldex Therapeutics, Inc. | 3.09B | -0.73% | 357,799 | 158.00K |
| 210 | IMNM | Immunome, Inc. | 3.06B | -1.81% | 444,847 | 4.02M |
| 211 | IRON | Disc Medicine, Inc. | 3.01B | -0.19% | 424,942 | - |
| 212 | WRBY | Warby Parker Inc. | 2.99B | -1.71% | 1,411,938 | 911.61M |
| 213 | NAMS | NewAmsterdam Pharma Company N.V. | 2.98B | -1.78% | 406,441 | 7.12M |
| 214 | ARQT | Arcutis Biotherapeutics, Inc. | 2.96B | -1.63% | 559,678 | 463.98M |
| 215 | MBX | MBX Biosciences, Inc. | 2.94B | -0.88% | 246,392 | - |
| 216 | AVAH | Aveanna Healthcare Holdings Inc. | 2.93B | 0.15% | 1,262,291 | 2.60B |
| 217 | BEAM | Beam Therapeutics Inc. | 2.91B | -0.99% | 552,475 | 156.04M |
| 218 | TMDX | TransMedics Group, Inc. | 2.86B | -2.95% | 533,441 | 668.47M |
| 219 | BKD | Brookdale Senior Living Inc. | 2.85B | 1.06% | 3,996,973 | 2.93B |
| 220 | ALHC | Alignment Healthcare, Inc. | 2.83B | 1.90% | 1,585,232 | 4.58B |
| 221 | ZLAB | Zai Lab Limited | 2.83B | -0.94% | 763,427 | 449.61M |
| 222 | ATAI | AtaiBeckley Inc. | 2.72B | 0.07% | 5,231,501 | 4.47M |
| 223 | RGC | Regencell Bioscience Holdings Limited | 2.70B | -1.09% | 67,047 | - |
| 224 | NRIX | Nurix Therapeutics, Inc. | 2.69B | 0.47% | 561,350 | 36.77M |
| 225 | AXGN | Axogen, Inc. | 2.69B | -1.60% | 408,560 | 251.17M |
| 226 | SLS | SELLAS Life Sciences Group, Inc. | 2.67B | -1.05% | 4,811,322 | - |
| 227 | PRVA | Privia Health Group, Inc. | 2.66B | 1.81% | 637,375 | 2.36B |
| 228 | ACHC | Acadia Healthcare Company, Inc. | 2.63B | 2.39% | 585,654 | 3.37B |
| 229 | VRDN | Viridian Therapeutics, Inc. | 2.61B | -0.47% | 679,646 | 71.13M |
| 230 | WGS | GeneDx Holdings Corp. | 2.54B | 0.55% | 224,032 | 454.43M |
| 231 | CDNA | CareDx, Inc. | 2.54B | -1.96% | 447,923 | 458.09M |
| 232 | SUPN | Supernus Pharmaceuticals, Inc. | 2.54B | -1.18% | 202,563 | 830.44M |
| 233 | NEOG | Neogen Corporation | 2.53B | 0.52% | 848,347 | 870.40M |
| 234 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.52B | 1.86% | 2,022,158 | 940.61M |
| 235 | RARE | Ultragenyx Pharmaceutical Inc. | 2.52B | 1.71% | 1,205,227 | 717.00M |
| 236 | PBH | Prestige Consumer Healthcare Inc. | 2.50B | 1.72% | 327,197 | 1.10B |
| 237 | ATRC | AtriCure, Inc. | 2.48B | 0.89% | 491,311 | 569.62M |
| 238 | GRDN | Guardian Pharmacy Services, Inc. | 2.47B | 5.28% | 359,720 | 1.46B |
| 239 | PGEN | Precigen, Inc. | 2.47B | -0.58% | 1,929,014 | 85.72M |
| 240 | VERA | Vera Therapeutics, Inc. | 2.46B | 0.21% | 720,843 | - |
| 241 | NKTR | Nektar Therapeutics | 2.45B | 0.60% | 184,338 | 54.59M |
| 242 | BHC | Bausch Health Companies Inc. | 2.44B | 2.43% | 1,960,074 | 10.85B |
| 243 | PHVS | Pharvaris N.V. | 2.44B | 0.27% | 181,615 | - |
| 244 | HRMY | Harmony Biosciences Holdings, Inc. | 2.39B | 4.34% | 487,605 | 959.90M |
| 245 | BHVN | Biohaven Ltd. | 2.38B | 3.21% | 1,793,601 | - |
| 246 | NUVB | Nuvation Bio Inc. | 2.36B | 1.05% | 3,058,795 | 169.90M |
| 247 | TRVI | Trevi Therapeutics, Inc. | 2.36B | -0.12% | 585,379 | - |
| 248 | RAPP | Rapport Therapeutics, Inc. | 2.35B | 0.55% | 49,356 | 20.00M |
| 249 | KOD | Kodiak Sciences Inc. | 2.34B | -0.27% | 225,648 | - |
| 250 | OCUL | Ocular Therapeutix, Inc. | 2.31B | 0.43% | 865,250 | 52.06M |
| 251 | UFPT | UFP Technologies, Inc. | 2.30B | -0.27% | 119,710 | 631.64M |
| 252 | CLOV | Clover Health Investments, Corp. | 2.28B | 3.49% | 2,644,690 | 2.48B |
| 253 | TRLV | Trulieve Cannabis Corp. | 2.25B | 1.74% | 1,172,864 | 1.14B |
| 254 | NEO | NeoGenomics, Inc. | 2.25B | -2.12% | 822,129 | 766.30M |
| 255 | SRPT | Sarepta Therapeutics, Inc. | 2.24B | 1.00% | 1,761,275 | 1.97B |
| 256 | MLYS | Mineralys Therapeutics, Inc. | 2.24B | -1.48% | 494,446 | - |
| 257 | KLRA | Kailera Therapeutics, Inc. | 2.18B | 9.35% | 928,413 | - |
| 258 | MESO | Mesoblast Limited | 2.17B | -1.67% | 145,326 | 120.25M |
| 259 | PVLA | Palvella Therapeutics, Inc. | 2.17B | -1.46% | 43,039 | - |
| 260 | XRAY | DENTSPLY SIRONA Inc. | 2.16B | -3.09% | 2,046,587 | 3.64B |
| 261 | BFLY | Butterfly Network, Inc. | 2.14B | 1.90% | 2,792,766 | 112.14M |
| 262 | AUPH | Aurinia Pharmaceuticals Inc. | 2.13B | -0.43% | 632,357 | 311.51M |
| 263 | HCM | HUTCHMED (China) Limited | 2.13B | -1.49% | 56,228 | 549.12M |
| 264 | URGN | UroGen Pharma Ltd. | 2.12B | 0.51% | 263,041 | 188.73M |
| 265 | ZYME | Zymeworks Inc. | 2.11B | 0.92% | 191,195 | 37.13M |
| 266 | MD | Pediatrix Medical Group, Inc. | 2.10B | 1.14% | 394,786 | 1.95B |
| 267 | ADUS | Addus HomeCare Corporation | 2.10B | 0.24% | 41,695 | 1.48B |
| 268 | ADMA | ADMA Biologics, Inc. | 2.09B | -0.53% | 1,133,741 | 512.28M |
| 269 | ESTA | Establishment Labs Holdings Inc. | 2.09B | 1.11% | 214,279 | 245.82M |
| 270 | ZBIO | Zenas BioPharma, Inc. | 2.09B | -0.90% | 250,345 | 1.00M |
| 271 | XNCR | Xencor, Inc. | 2.07B | 2.31% | 838,046 | 104.97M |
| 272 | VCEL | Vericel Corporation | 2.07B | 1.13% | 366,364 | 306.30M |
| 273 | COAG | Hemab Therapeutics Holdings, Inc. | 2.06B | -3.41% | 241,931 | - |
| 274 | GENB | Generate Biomedicines, Inc. | 2.05B | 4.45% | 821,571 | 26.48M |
| 275 | NBTX | Nanobiotix S.A. | 2.04B | -3.19% | 57,564 | 38.27M |
| 276 | AGIO | Agios Pharmaceuticals, Inc. | 2.03B | 1.13% | 265,289 | 98.34M |
| 277 | ALMR | Alamar Biosciences, Inc. | 2.03B | -4.13% | 117,786 | 100.42M |
| 278 | NVCR | NovoCure Limited | 2.02B | -1.53% | 438,803 | 699.19M |
| 279 | STOK | Stoke Therapeutics, Inc. | 2.01B | -0.32% | 282,174 | 27.59M |
| 280 | PRGO | Perrigo Company plc | 2.00B | -1.64% | 1,216,215 | 4.14B |
| 281 | PGNY | Progyny, Inc. | 1.97B | 0.31% | 394,415 | 1.31B |
| 282 | ASTH | Astrana Health, Inc. | 1.96B | 0.71% | 160,063 | 3.84B |
| 283 | VIR | Vir Biotechnology, Inc. | 1.95B | 5.30% | 1,991,327 | 303.23M |
| 284 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.91B | -3.93% | 1,576,151 | 208.78M |
| 285 | GHRS | GH Research PLC | 1.89B | 2.30% | 72,184 | - |
| 286 | IMCR | Immunocore Holdings plc | 1.89B | 1.21% | 705,978 | 430.78M |
| 287 | SGRY | Surgery Partners, Inc. | 1.89B | 5.04% | 2,760,798 | 3.37B |
| 288 | TSHA | Taysha Gene Therapies, Inc. | 1.86B | 0.53% | 853,481 | 5.49M |
| 289 | LMAT | LeMaitre Vascular, Inc. | 1.86B | 1.26% | 143,022 | 262.43M |
| 290 | LKFT | Lakefront Biotherapeutics NV | 1.86B | - | 116,536 | 1.13B |
| 291 | ALVO | Alvotech | 1.85B | - | 609,952 | 494.61M |
| 292 | CMPS | COMPASS Pathways plc | 1.84B | -1.55% | 1,406,454 | - |
| 293 | KARD | Kardigan, Inc. | 1.83B | -2.85% | 151,450 | - |
| 294 | SNDA | Sonida Senior Living, Inc. | 1.82B | 2.25% | 465,282 | 481.07M |
| 295 | PSNL | Personalis, Inc. | 1.80B | 0.45% | 2,905,617 | 69.67M |
| 296 | INBX | Inhibrx Biosciences, Inc. | 1.79B | -3.82% | 177,948 | 1.30M |
| 297 | SNDX | Syndax Pharmaceuticals, Inc. | 1.79B | 4.04% | 898,718 | 252.25M |
| 298 | RXRX | Recursion Pharmaceuticals, Inc. | 1.79B | -1.76% | 7,787,479 | 54.86M |
| 299 | NTLA | Intellia Therapeutics, Inc. | 1.78B | -0.12% | 1,589,071 | 59.51M |
| 300 | INSP | Inspire Medical Systems, Inc. | 1.78B | -2.21% | 227,368 | 898.74M |
| 301 | SEPN | Septerna, Inc. | 1.76B | -1.15% | 167,201 | 98.88M |
| 302 | ETON | Eton Pharmaceuticals, Inc. | 1.75B | 1.21% | 325,158 | 105.60M |
| 303 | DMRA | Damora Therapeutics, Inc. | 1.73B | -0.82% | 173,462 | - |
| 304 | BLFS | BioLife Solutions, Inc. | 1.72B | -5.10% | 785,622 | 106.69M |
| 305 | FTRE | Fortrea Holdings Inc. | 1.69B | -3.51% | 847,028 | 2.68B |
| 306 | BRVE | Braveheart Bio, Inc. | 1.68B | 2.51% | 271,454 | - |
| 307 | NVAX | Novavax, Inc. | 1.67B | 8.06% | 7,137,084 | 413.80M |
| 308 | FRNM | Freenome, Inc. | 1.64B | 3.25% | 1,569,442 | 35.41M |
| 309 | ANAB | AnaptysBio, Inc. | 1.64B | -3.14% | 557,286 | 232.39M |
| 310 | SDGR | Schrödinger, Inc. | 1.57B | 7.59% | 1,033,579 | 259.04M |
| 311 | AVLN | Avalyn Pharma Inc. | 1.56B | 1.44% | 127,663 | - |
| 312 | OMCL | Omnicell, Inc. | 1.56B | -2.82% | 487,352 | 1.25B |
| 313 | PAHC | Phibro Animal Health Corporation | 1.56B | 1.70% | 254,909 | 1.52B |
| 314 | SLBT | SL Science Holding Limited | 1.56B | - | 7,658 | 3.27M |
| 315 | ARDT | Ardent Health, Inc. | 1.55B | 1.66% | 178,723 | 6.41B |
| 316 | XERS | Xeris Biopharma Holdings, Inc. | 1.55B | 0.47% | 776,093 | 335.41M |
| 317 | BCAX | Bicara Therapeutics Inc. | 1.54B | 0.87% | 212,374 | - |
| 318 | ANIP | ANI Pharmaceuticals, Inc. | 1.54B | -1.79% | 343,894 | 978.38M |
| 319 | LBRX | LB Pharmaceuticals Inc | 1.52B | -0.17% | 108,695 | - |
| 320 | TYRA | Tyra Biosciences, Inc. | 1.52B | 1.88% | 261,315 | - |
| 321 | INVA | Innoviva, Inc. | 1.52B | 1.30% | 310,681 | 440.00M |
| 322 | ABSI | Absci Corporation | 1.52B | -2.21% | 2,503,136 | 1.56M |
| 323 | AAPG | Ascentage Pharma Group International | 1.51B | -3.07% | 4,105 | 94.61M |
| 324 | HCSG | Healthcare Services Group, Inc. | 1.50B | -0.36% | 367,299 | 1.86B |
| 325 | AVBP | ArriVent BioPharma, Inc. | 1.49B | 0.43% | 245,567 | - |
| 326 | INNV | InnovAge Holding Corp. | 1.49B | 1.48% | 112,240 | 949.17M |
| 327 | TNDM | Tandem Diabetes Care, Inc. | 1.48B | -3.18% | 486,465 | 1.04B |
| 328 | APMD | Apnimed, Inc. | 1.48B | 1.83% | 315,672 | 120.15M |
| 329 | KMTS | Kestra Medical Technologies, Ltd. | 1.48B | -1.90% | 217,610 | 95.13M |
| 330 | TRAX | First Tracks Biotherapeutics, Inc. | 1.47B | -1.36% | 342,101 | - |
| 331 | MAZE | Maze Therapeutics, Inc. | 1.47B | -0.15% | 188,507 | 20.00M |
| 332 | CNMD | CONMED Corporation | 1.47B | -1.69% | 106,069 | 1.37B |
| 333 | AGL | agilon health, inc. | 1.47B | -0.53% | 62,009 | 5.92B |
| 334 | REPL | Replimune Group, Inc. | 1.46B | 1.57% | 1,231,539 | - |
| 335 | AKTS | Aktis Oncology, Inc. | 1.44B | 0.19% | 87,873 | 10.06M |
| 336 | LTGO | Latigo Biotherapeutics, Inc. | 1.43B | 2.45% | 245,844 | - |
| 337 | ATEC | Alphatec Holdings, Inc. | 1.42B | -1.81% | 668,234 | 815.05M |
| 338 | CGEM | Cullinan Therapeutics, Inc. | 1.40B | -1.22% | 267,640 | - |
| 339 | OMDA | Omada Health, Inc. | 1.40B | -6.88% | 845,236 | 309.76M |
| 340 | HROW | Harrow, Inc. | 1.39B | 0.70% | 217,087 | 275.59M |
| 341 | ANRO | Alto Neuroscience, Inc. | 1.37B | -1.02% | 237,092 | - |
| 342 | AZTA | Azenta, Inc. | 1.37B | -4.35% | 679,229 | 613.81M |
| 343 | MGTX | MeiraGTx Holdings plc | 1.37B | 3.04% | 613,454 | 397.50M |
| 344 | SVRA | Savara Inc. | 1.36B | -0.83% | 643,546 | - |
| 345 | OMER | Omeros Corporation | 1.35B | -0.48% | 830,855 | 38.42M |
| 346 | JBIO | Jade Biosciences, Inc. | 1.35B | -0.47% | 320,265 | - |
| 347 | ORIC | ORIC Pharmaceuticals, Inc. | 1.34B | -0.69% | 364,024 | - |
| 348 | VOR | Vor Biopharma Inc. | 1.33B | 0.36% | 427,733 | - |
| 349 | AORT | Artivion, Inc. | 1.32B | 0.09% | 421,318 | 471.47M |
| 350 | PNTG | The Pennant Group, Inc. | 1.31B | 2.37% | 178,817 | 1.10B |
| 351 | AMN | AMN Healthcare Services, Inc. | 1.30B | -2.19% | 268,835 | 3.43B |
| 352 | MLTX | MoonLake Immunotherapeutics | 1.30B | 1.33% | 384,076 | - |
| 353 | DRTS | Alpha Tau Medical Ltd. | 1.29B | -0.92% | 363,969 | - |
| 354 | IART | Integra LifeSciences Holdings Corporation | 1.29B | -2.13% | 361,350 | 1.65B |
| 355 | IMTX | Immatics N.V. | 1.28B | -1.47% | 312,142 | 47.65M |
| 356 | MNKD | MannKind Corporation | 1.28B | -1.00% | 1,443,410 | 393.63M |
| 357 | NUTX | Nutex Health Inc. | 1.27B | -1.49% | 179,651 | 846.72M |
| 358 | SPTX | Seaport Therapeutics, Inc. | 1.26B | -0.63% | 52,705 | - |
| 359 | CERT | Certara, Inc. | 1.24B | -2.05% | 787,297 | 421.75M |
| 360 | CRON | Cronos Group Inc. | 1.24B | 0.45% | 972,984 | 179.09M |
| 361 | ALMS | Alumis Inc. | 1.23B | -56.35% | 24,939,734 | 7.40M |
| 362 | ENOV | Enovis Corporation | 1.23B | -13.46% | 2,649,270 | 2.30B |
| 363 | GLUE | Monte Rosa Therapeutics, Inc. | 1.21B | 2.08% | 552,635 | 28.73M |
| 364 | ODTX | Odyssey Therapeutics, Inc. | 1.21B | 2.85% | 128,052 | 99.00K |
| 365 | PRCT | PROCEPT BioRobotics Corporation | 1.20B | -0.99% | 662,211 | 337.34M |
| 366 | CRVS | Corvus Pharmaceuticals, Inc. | 1.19B | 1.10% | 236,197 | - |
| 367 | GDRX | GoodRx Holdings, Inc. | 1.19B | -0.43% | 829,952 | 785.23M |
| 368 | STAA | STAAR Surgical Company | 1.18B | 4.29% | 521,953 | 339.59M |
| 369 | USPH | U.S. Physical Therapy, Inc. | 1.16B | 0.33% | 33,097 | 804.27M |
| 370 | BVS | Bioventus Inc. | 1.15B | 0.51% | 413,549 | 581.85M |
| 371 | SANA | Sana Biotechnology, Inc. | 1.15B | -1.03% | 1,243,963 | - |
| 372 | KURA | Kura Oncology, Inc. | 1.14B | 1.66% | 957,645 | 77.23M |
| 373 | JANX | Janux Therapeutics, Inc. | 1.14B | 2.69% | 695,461 | 24.00M |
| 374 | TDOC | Teladoc Health, Inc. | 1.14B | -0.79% | 2,170,125 | 2.49B |
| 375 | OPK | OPKO Health, Inc. | 1.12B | 1.70% | 2,088,920 | 587.90M |
| 376 | IVA | Inventiva S.A. | 1.11B | 2.76% | 693,825 | 7.94M |
| 377 | LMRI | Lumexa Imaging Holdings, Inc. | 1.11B | -1.20% | 139,348 | 1.04B |
| 378 | IRMD | IRADIMED CORPORATION | 1.10B | -0.01% | 16,174 | 86.34M |
| 379 | SLDB | Solid Biosciences Inc. | 1.06B | 3.13% | 508,425 | - |
| 380 | PCRX | Pacira BioSciences, Inc. | 1.05B | 1.85% | 189,767 | 746.16M |
| 381 | CSTL | Castle Biosciences, Inc. | 1.04B | 2.79% | 224,912 | 357.28M |
| 382 | AVTX | Avalo Therapeutics, Inc. | 1.02B | -1.19% | 360,430 | 59.00K |
| 383 | ABUS | Arbutus Biopharma Corporation | 1.01B | 0.10% | 1,334,323 | 181.72M |
| 384 | GMRS | GMR Solutions Inc. | 1.00B | 6.42% | 656,286 | 5.88B |
| 385 | IMMX | Immix Biopharma, Inc. | 1.00B | -0.21% | 1,030,460 | - |
| 386 | CADL | Candel Therapeutics, Inc. | 985.56M | -1.45% | 715,463 | - |
| 387 | AMPH | Amphastar Pharmaceuticals, Inc. | 975.82M | 1.82% | 190,535 | 730.02M |
| 388 | WVE | Wave Life Sciences, Inc. | 974.40M | 0.92% | 1,708,347 | 65.37M |
| 389 | LXRX | Lexicon Pharmaceuticals, Inc. | 970.00M | -3.11% | 1,463,787 | 41.47M |
| 390 | QDEL | QuidelOrtho Corporation | 958.68M | -3.12% | 348,395 | 2.67B |
| 391 | GERN | Geron Corporation | 954.07M | -0.34% | 4,501,025 | 204.56M |
| 392 | ATTO | Attovia Therapeutics, Inc. | 946.21M | 2.76% | 163,838 | 1.35M |
| 393 | DSGN | Design Therapeutics, Inc. | 945.61M | 0.13% | 350,544 | - |
| 394 | ARDX | Ardelyx, Inc. | 939.44M | -0.26% | 1,219,741 | 450.89M |
| 395 | CBLL | CeriBell, Inc. | 937.58M | 1.88% | 159,056 | 101.96M |
| 396 | OLMA | Olema Pharmaceuticals, Inc. | 929.22M | 1.82% | 470,103 | - |
| 397 | ANNX | Annexon, Inc. | 921.35M | -1.62% | 945,687 | - |
| 398 | SLN | Silence Therapeutics plc | 889.89M | 9.24% | 896,473 | 615.00K |
| 399 | SGP | SpyGlass Pharma, Inc. | 889.38M | 1.88% | 60,027 | - |
| 400 | FTH | Faeth Therapeutics, Inc. | 888.65M | 4.94% | 224,626 | - |
| 401 | ACRS | Aclaris Therapeutics, Inc. | 885.40M | -0.58% | 1,086,842 | 8.22M |
| 402 | RIGL | Rigel Pharmaceuticals, Inc. | 885.33M | 2.63% | 120,976 | 276.79M |
| 403 | TBPH | Theravance Biopharma, Inc. | 885.21M | 0.06% | 469,570 | 104.31M |
| 404 | ANL | Adlai Nortye Group Ltd. | 877.74M | -3.95% | 84,133 | 18.06M |
| 405 | BBNX | Beta Bionics, Inc. | 867.85M | -3.31% | 296,726 | 119.01M |
| 406 | INMD | InMode Ltd. | 866.81M | 0.80% | 536,547 | 374.63M |
| 407 | HSTM | HealthStream, Inc. | 859.07M | 1.14% | 131,643 | 321.12M |
| 408 | HELP | Cybin Inc. | 851.88M | -0.85% | 994,992 | - |
| 409 | ACHV | Achieve Life Sciences, Inc. | 849.97M | 4.03% | 1,210,377 | - |
| 410 | CLYM | Climb Bio, Inc. | 849.48M | 7.72% | 1,472,590 | - |
| 411 | SIBN | SI-BONE, Inc. | 839.45M | -1.52% | 294,441 | 213.60M |
| 412 | AVR | Anteris Technologies Global Corp. | 827.91M | -1.34% | 346,220 | 2.24M |
| 413 | PHAR | Pharming Group N.V. | 811.69M | -3.75% | 33,911 | 366.48M |
| 414 | CTMX | CytomX Therapeutics, Inc. | 804.05M | 9.82% | 6,832,260 | 18.30M |
| 415 | GLAS | Glass House Brands Inc. | 802.00M | -4.70% | 631,895 | 176.98M |
| 416 | FDMT | 4D Molecular Therapeutics, Inc. | 796.07M | 2.13% | 414,710 | 92.01M |
| 417 | DBVT | DBV Technologies S.A. | 794.50M | -3.62% | 94,479 | 5.04M |
| 418 | COLL | Collegium Pharmaceutical, Inc. | 785.57M | -1.95% | 607,863 | 808.21M |
| 419 | VREX | Varex Imaging Corporation | 778.68M | -0.08% | 571,491 | 865.00M |
| 420 | AURA | Aura Biosciences, Inc. | 776.75M | 4.32% | 337,732 | - |
| 421 | AHG | Akso Health Group | 771.03M | - | 793 | 13.83M |
| 422 | MNPR | Monopar Therapeutics Inc. | 766.80M | 2.06% | 77,490 | - |
| 423 | CBIO | Crescent Biopharma, Inc. | 766.14M | 7.83% | 719,164 | 11.88M |
| 424 | NGNE | Neurogene Inc. | 759.63M | 4.75% | 98,408 | 925.00K |
| 425 | MPLT | MapLight Therapeutics, Inc. | 756.39M | 4.93% | 392,553 | - |
| 426 | NVCT | Nuvectis Pharma, Inc. | 754.91M | 1.94% | 120,516 | - |
| 427 | OBX | Obsidian Therapeutics, Inc. | 754.74M | -0.51% | 73,785 | - |
| 428 | OCS | Oculis Holding AG | 753.13M | -0.41% | 52,853 | 1.45M |
| 429 | PHAT | Phathom Pharmaceuticals, Inc. | 739.49M | -2.72% | 589,413 | 239.66M |
| 430 | AHCO | AdaptHealth Corp. | 734.42M | -1.52% | 1,221,360 | 3.36B |
| 431 | PHR | Phreesia, Inc. | 732.47M | -2.95% | 294,064 | 495.59M |
| 432 | SOPH | SOPHiA GENETICS SA | 715.07M | - | 678,411 | 86.17M |
| 433 | ASMB | Assembly Biosciences, Inc. | 714.05M | 4.28% | 232,231 | 74.85M |
| 434 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 710.34M | 0.68% | 89,201 | - |
| 435 | ZVRA | Zevra Therapeutics, Inc. | 710.23M | 1.87% | 714,985 | 136.07M |
| 436 | IRWD | Ironwood Pharmaceuticals, Inc. | 708.05M | 0.82% | 904,530 | 389.32M |
| 437 | DRUG | Bright Minds Biosciences Inc. | 700.83M | -1.62% | 47,740 | - |
| 438 | STTK | Shattuck Labs, Inc. | 688.49M | -2.14% | 473,429 | 1.00M |
| 439 | VSTM | Verastem, Inc. | 685.11M | 4.78% | 1,164,158 | 87.53M |
| 440 | ALLO | Allogene Therapeutics, Inc. | 684.07M | -1.00% | 3,436,546 | 4.64M |
| 441 | GYRE | Gyre Therapeutics, Inc. | 679.68M | -2.44% | 37,222 | 109.82M |
| 442 | CTEV | Claritev Corporation | 677.39M | 0.35% | 93,197 | 994.67M |
| 443 | SSII | SS Innovations International, Inc. | 676.30M | -1.03% | 44,959 | 52.40M |
| 444 | AGMB | AgomAb Therapeutics NV | 671.74M | 3.57% | 219,828 | - |
| 445 | EVO | Evotec SE | 670.12M | -3.72% | 36,165 | 819.47M |
| 446 | MDXG | MiMedx Group, Inc. | 661.02M | -0.11% | 413,334 | 355.17M |
| 447 | AQST | Aquestive Therapeutics, Inc. | 656.43M | 2.35% | 1,700,136 | 54.09M |
| 448 | ANGO | AngioDynamics, Inc. | 654.71M | -1.80% | 136,041 | 320.17M |
| 449 | SGMT | Sagimet Biosciences Inc. | 654.53M | 2.63% | 498,955 | - |
| 450 | CRMD | CorMedix Inc. | 653.17M | 1.45% | 623,023 | 462.25M |
| 451 | OABI | OmniAb, Inc. | 632.45M | -0.68% | 624,495 | 38.46M |
| 452 | PRME | Prime Medicine, Inc. | 631.56M | -1.11% | 1,888,924 | 4.07M |
| 453 | CTNM | Contineum Therapeutics, Inc. | 629.40M | 3.02% | 147,501 | - |
| 454 | RGNX | REGENXBIO Inc. | 617.88M | -1.47% | 552,856 | 174.48M |
| 455 | AUTL | Autolus Therapeutics plc | 617.50M | -1.28% | 1,157,431 | 117.39M |
| 456 | STLN | Starling Oncology, Inc. | 615.06M | 2.12% | 620,929 | 587.24M |
| 457 | TLRY | Tilray Brands, Inc. | 613.65M | -0.98% | 3,022,184 | 915.45M |
| 458 | TECX | Tectonic Therapeutic, Inc. | 613.26M | 4.78% | 92,080 | - |
| 459 | ARVN | Arvinas, Inc. | 604.17M | 0.43% | 287,259 | 316.70M |
| 460 | ALT | Altimmune, Inc. | 599.11M | -0.96% | 1,738,190 | 31.00K |
| 461 | EOLS | Evolus, Inc. | 597.76M | -0.44% | 377,795 | 316.49M |
| 462 | CTKB | Cytek Biosciences, Inc. | 597.27M | -3.87% | 409,664 | 206.71M |
| 463 | KIDS | OrthoPediatrics Corp. | 596.74M | -1.95% | 101,902 | 252.72M |
| 464 | VALN | Valneva SE | 596.47M | 4.13% | 25,423 | 163.30M |
| 465 | BLSM | BlossomHill Therapeutics, Inc. | 588.36M | 4.92% | 116,840 | - |
| 466 | CAPR | Capricor Therapeutics, Inc. | 584.30M | 1.41% | 4,991,383 | 11.13M |
| 467 | WEAV | Weave Communications, Inc. | 583.99M | -0.14% | 2,759,627 | 257.79M |
| 468 | EIKN | Eikon Therapeutics, Inc. | 583.36M | 2.96% | 224,556 | - |
| 469 | SPRY | ARS Pharmaceuticals, Inc. | 578.78M | -3.00% | 846,929 | 116.93M |
| 470 | BWAY | BrainsWay Ltd. | 572.38M | -1.93% | 55,682 | 60.70M |
| 471 | SCTX | Scribe Therapeutics Inc. | 572.35M | -0.65% | 41,887 | 36.28M |
| 472 | DCTH | Delcath Systems, Inc. | 567.67M | -0.61% | 201,824 | 95.42M |
| 473 | PRLD | Prelude Therapeutics Incorporated | 566.47M | -1.79% | 446,340 | 22.42M |
| 474 | PROK | ProKidney Corp. | 565.34M | -1.06% | 580,469 | 818.00K |
| 475 | CABA | Cabaletta Bio, Inc. | 551.02M | 4.50% | 5,300,545 | - |
| 476 | ARTV | Artiva Biotherapeutics, Inc. | 550.50M | -0.35% | 179,445 | 251.00K |
| 477 | FLGT | Fulgent Genetics, Inc. | 542.60M | 1.81% | 208,286 | 323.93M |
| 478 | ZURA | Zura Bio Limited | 542.39M | 2.17% | 663,735 | - |
| 479 | OVID | Ovid Therapeutics Inc. | 540.98M | 3.75% | 836,755 | 1.58M |
| 480 | CERS | Cerus Corporation | 520.94M | -2.08% | 582,430 | 221.55M |
| 481 | KYTX | Kyverna Therapeutics, Inc. | 518.87M | -1.00% | 1,500,740 | - |
| 482 | TCMD | Tactile Systems Technology, Inc. | 506.96M | -2.61% | 158,871 | 350.31M |
| 483 | NPCE | NeuroPace, Inc. | 504.74M | 0.38% | 52,160 | 106.99M |
| 484 | MCTA | Charming Medical Limited | 504.26M | -0.83% | - | 4.81M |
| 485 | ENTX | Entera Bio Ltd. | 501.25M | -1.86% | 219,096 | 42.00K |
| 486 | SENS | Senseonics Holdings, Inc. | 499.40M | 2.33% | 656,700 | 48.55M |
| 487 | PRTA | Prothena Corporation plc | 491.81M | 2.46% | 144,099 | 54.53M |
| 488 | PBYI | Puma Biotechnology, Inc. | 488.58M | 3.90% | 371,476 | 231.24M |
| 489 | EVH | Evolent Health, Inc. | 480.50M | -5.56% | 1,564,099 | 2.10B |
| 490 | EDIT | Editas Medicine, Inc. | 479.17M | 1.96% | 893,469 | 47.01M |
| 491 | SRTA | Strata Critical Medical, Inc. | 476.39M | -4.86% | 801,652 | 255.98M |
| 492 | KMDA | Kamada Ltd. | 474.61M | 1.94% | 147,522 | 191.85M |
| 493 | RLMD | Relmada Therapeutics, Inc. | 473.61M | 1.83% | 539,694 | - |
| 494 | CCCC | C4 Therapeutics, Inc. | 472.42M | 3.50% | 2,003,558 | 35.04M |
| 495 | DNA | Ginkgo Bioworks Holdings, Inc. | 466.67M | 1.76% | 1,467,687 | 132.42M |
| 496 | VOGX | Vogenx, Inc. | 464.15M | -1.91% | 326,905 | - |
| 497 | RZLT | Rezolute, Inc. | 463.83M | -5.33% | 599,965 | - |
| 498 | ARCT | Arcturus Therapeutics Holdings Inc. | 461.02M | 9.89% | 1,157,305 | 29.37M |
| 499 | NRC | NRC Health | 456.22M | -1.50% | 47,690 | 140.00M |
| 500 | CLPT | ClearPoint Neuro, Inc. | 455.73M | -1.32% | 588,364 | 42.28M |